FAPON
LIVE

Serial Number

79074914

Owner

FAPON BIOTECH INC.

Attorney

Nazly Aileen Bayramoglu

Filing Date

Jul 28, 2009

Add to watchlist:

No watchlists yet
View on USPTO

FAPON Trademark

Serial Number: 79074914 • Registration: 3927834

FAPON is a trademark filed by FAPON BIOTECH INC. on July 28, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

FAPON BIOTECH INC. (5 trademarks)

EAST 6TH FL., BUILD.3, THE 4TH NANYOU
GUANGDONG, SHENZHEN 518054 , CN

Entity Type: 03

Shenzhen Feipeng Kechuang partnership (L.P.) (4 trademarks)

C401, Building C4, Phase I of Merchants

Entity Type: 99

Trademark Details

Filing Date

July 28, 2009

Registration Date

March 8, 2011

Published for Opposition

August 24, 2010

Goods & Services

Vaccines; biological preparations for medical purposes; diagnostic preparations for medical purposes; bacterial and bacteriological preparations for medical or veterinary purposes; blood derivatives, namely, hematology calibrators and controls, blood plasma, blood substitutes for human or veterinary use, coagulation factor, immunoglobulin, tissue type plasminogen activator, C-reactive protein, and human antithrombin; veterinary preparations for treatment of intestinal bacteria; anti-infective products for veterinary use; pharmaceutical preparations for the treatment of addiction in the fields of smoking or drugs; pharmaceutical preparations for the treatment of urinary incontinence; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of cerebrovascular diseases and disorders; pharmaceutical preparations for the treatment of anxiety, depression, insomnia, cognitive disorders and diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of menopausal symptoms and disorders; pharmaceutical preparations, namely, anti-infective preparations; pharmaceutical preparations, namely, anti-viral preparations; pharmaceutical preparations, namely, immunological preparations; pharmaceutical preparations, namely, analgesic preparations; pharmaceutical preparations, namely, antiemetic preparations; pharmaceutical preparations, namely, vaccine preparations; biochemical preparations for medical or veterinary purposes; bacterial preparations for medical and veterinary use; none of the foregoing being ophthalmic preparations or otorhinolaryngological preparations

Diagnostic preparations, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, antibodies, antigens, peptides, enzymes, lysates, vectors, lipids, stem cells, cell strains, strains, tags and markers, namely, tag and marker antibodies, antigens and proteins, all for research purposes; cultures of microorganisms other than for medical and veterinary use; biochemical catalysts; chemical reagents for non-medical purposes

Testing apparatus for medical purposes, namely, skin allergy testing apparatus; testing apparatus for medical purposes, namely, blood glucose testing apparatus in the nature of blood glucose meter and blood drawing apparatus; apparatus and instruments for medical and veterinary diagnosis, namely, equipments and devices in the nature of immuno analysers, nucleid acid analysers; bacteriologic analysers, microbiologic analysers used for testing or for manual or for automated testing in medical and clinical applications; medical diagnostic apparatus for medical purposes, namely, ultrasonic and magnetic resonance imaging diagnostic apparatus, X-ray computer tomography scanners, computed tomography (CT) apparatus, and diagnostic X-ray apparatus; blood testing apparatus

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 28, 2021 NA71
REGISTERED-SEC.71 ACCEPTED
Apr 28, 2021 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 28, 2021 APRE
TEAS SECTION 71 RECEIVED
Mar 5, 2021 ES71
CHANGE OF OWNER RECEIVED FROM IB
Oct 31, 2020 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Jun 18, 2020 CHLD
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
May 19, 2020 CORV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 20, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 20, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 20, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 20, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 20, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 20, 2020 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Mar 8, 2020 REM4
INTERNATIONAL REGISTRATION RENEWED
Aug 15, 2019 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Mar 15, 2019 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2019 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 27, 2018 TCCA
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 17, 2017 NA71
REGISTERED-SEC.71 ACCEPTED
Aug 17, 2017 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 17, 2017 APRE
TEAS SECTION 71 RECEIVED
Jul 28, 2017 ES71
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 24, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 15, 2011 FICS
FINAL DISPOSITION PROCESSED
Jun 15, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 8, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2011 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jan 7, 2011 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Dec 2, 2010 CHPB
ASSIGNED TO PETITION STAFF
Nov 10, 2010 APET
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 9, 2010 TCCA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 9, 2010 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Sep 16, 2010 ETOF
PUBLISHED FOR OPPOSITION
Aug 24, 2010 PUBO
NOTICE OF PUBLICATION
Aug 4, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 22, 2010 PREV
ASSIGNED TO LIE
Jul 22, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 6, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2010 TROA
REFUSAL PROCESSED BY IB
Jan 1, 2010 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2009 RFCS
REFUSAL PROCESSED BY MPU
Dec 9, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 7, 2009 RFCR
NON-FINAL ACTION WRITTEN
Dec 6, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Dec 5, 2009 MAFR
ASSIGNED TO EXAMINER
Dec 1, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2009 NWOS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Nov 30, 2009 LIMS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 26, 2009 REPR